Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06444594 · ClinicalTrials.gov registry record · Early Phase 1

Transient Receptor Potential Channels

A Early Phase 1 study of Aging, sponsored by Penn State University.

Recruiting
Registry status
Early Phase 1
Development phase
45
Enrollment target
1
Study location

NCT06444594 is a Early Phase 1 study of Aging that is actively recruiting participants, run by Penn State University. The registered enrollment target is 45 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06444594, a Early Phase 1 study of Aging, is actively recruiting participants, sponsored by Penn State University.

RECRUITING
Registry status
Early Phase 1
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

Neurovascular signaling in the skin associated with stimulation of the transient receptor potential (TRP) channels. These channels are stimulated by both temperature and naturally occurring bioactive agents found in mint, chili peppers, garlic, etc. The aim of the study is to examine how topically applied TRP channel agonists including menthol, capsaicin and camphor impact neurovascular responses in the skin.

Conditions Studied

Interventions

  • DRUG TRPM8 Agonist
  • DRUG TRPV1 Agonist
  • DRUG TRPV4 Agonist
  • DRUG TRPM8, TRPV4, TRPV1 Agonists
  • OTHER Vehicle gel

Study Locations (1)

Pennsylvania

  • Noll Laboratory - University Park

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2024-07-17
Est. Completion 2026-12-31
Phase Early Phase 1

Sponsor

Penn State University

219 total trials

What the Registry Record Tells You About NCT06444594

The ClinicalTrials.gov registry entry for NCT06444594 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (98% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 5 interventions - of which TRPM8 Agonist is the first listed.

NCT06444594 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06444594 about?

NCT06444594 is a clinical study titled "Transient Receptor Potential Channels". Neurovascular signaling in the skin associated with stimulation of the transient receptor potential (TRP) channels. These channels are stimulated by both temperature and naturally occurring bioactive agents found in mint, chili peppers, garlic, etc. The aim of the study is to examine how topically a...

What is the current status of trial NCT06444594?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 45 participants. The study started on 2024-07-17. Estimated completion is 2026-12-31.

What conditions does trial NCT06444594 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT06444594?

The interventions under investigation include: TRPM8 Agonist (DRUG), TRPV1 Agonist (DRUG), TRPV4 Agonist (DRUG), TRPM8, TRPV4, TRPV1 Agonists (DRUG), Vehicle gel (OTHER).

Who is sponsoring clinical trial NCT06444594?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06444594 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.